287 related articles for article (PubMed ID: 23551844)
1. Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.
Christopher L; Strafella AP
J Neuropsychol; 2013 Sep; 7(2):225-40. PubMed ID: 23551844
[TBL] [Abstract][Full Text] [Related]
2. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
3. Neural Correlates of Cognitive Impairment in Parkinson's Disease: A Review of Structural MRI Findings.
Hall JM; Lewis SJG
Int Rev Neurobiol; 2019; 144():1-28. PubMed ID: 30638452
[TBL] [Abstract][Full Text] [Related]
4. Cognitive status correlates with white matter alteration in Parkinson's disease.
Hattori T; Orimo S; Aoki S; Ito K; Abe O; Amano A; Sato R; Sakai K; Mizusawa H
Hum Brain Mapp; 2012 Mar; 33(3):727-39. PubMed ID: 21495116
[TBL] [Abstract][Full Text] [Related]
5. Grey matter atrophy in cognitively impaired Parkinson's disease.
Melzer TR; Watts R; MacAskill MR; Pitcher TL; Livingston L; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):188-94. PubMed ID: 21890574
[TBL] [Abstract][Full Text] [Related]
6. Neurobiology of cognitive impairment in Parkinson's disease.
Jellinger KA
Expert Rev Neurother; 2012 Dec; 12(12):1451-66. PubMed ID: 23237352
[TBL] [Abstract][Full Text] [Related]
7. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
Dalaker TO; Larsen JP; Dwyer MG; Aarsland D; Beyer MK; Alves G; Bronnick K; Tysnes OB; Zivadinov R
Neuroimage; 2009 Oct; 47(4):2083-9. PubMed ID: 19539037
[TBL] [Abstract][Full Text] [Related]
8. Neuroimaging outcomes associated with mild cognitive impairment subtypes in Parkinson's disease: A systematic review.
Devignes Q; Lopes R; Dujardin K
Parkinsonism Relat Disord; 2022 Feb; 95():122-137. PubMed ID: 35249807
[TBL] [Abstract][Full Text] [Related]
9. Mild cognitive impairment in Parkinson's disease.
Aarsland D; Brønnick K; Fladby T
Curr Neurol Neurosci Rep; 2011 Aug; 11(4):371-8. PubMed ID: 21487730
[TBL] [Abstract][Full Text] [Related]
10. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
[TBL] [Abstract][Full Text] [Related]
11. Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD).
Nobili F; Morbelli S; Arnaldi D; Ferrara M; Campus C; Brugnolo A; Mazzei D; Mehrdad N; Sambuceti G; Rodriguez G
J Neurol Sci; 2011 Nov; 310(1-2):31-5. PubMed ID: 21762928
[TBL] [Abstract][Full Text] [Related]
12. Brain degeneration in Parkinson's disease patients with cognitive decline: a coordinate-based meta-analysis.
Mihaescu AS; Masellis M; Graff-Guerrero A; Kim J; Criaud M; Cho SS; Ghadery C; Valli M; Strafella AP
Brain Imaging Behav; 2019 Aug; 13(4):1021-1034. PubMed ID: 29971686
[TBL] [Abstract][Full Text] [Related]
13. Subcortical shape analysis of progressive mild cognitive impairment in Parkinson's disease.
Chung SJ; Shin JH; Cho KH; Lee Y; Sohn YH; Seong JK; Lee PH
Mov Disord; 2017 Oct; 32(10):1447-1456. PubMed ID: 28737237
[TBL] [Abstract][Full Text] [Related]
14. Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
Lyoo CH; Jeong Y; Ryu YH; Rinne JO; Lee MS
Eur Neurol; 2010; 64(2):65-73. PubMed ID: 20606450
[TBL] [Abstract][Full Text] [Related]
15. Neuroimaging correlates of cognitive impairment and dementia in Parkinson's disease.
Mak E; Su L; Williams GB; O'Brien JT
Parkinsonism Relat Disord; 2015 Aug; 21(8):862-70. PubMed ID: 26004683
[TBL] [Abstract][Full Text] [Related]
16. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
Shin J; Choi S; Lee JE; Lee HS; Sohn YH; Lee PH
J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):315-21. PubMed ID: 22228726
[TBL] [Abstract][Full Text] [Related]
17. Relationship between cognitive impairment and white-matter alteration in Parkinson's disease with dementia: tract-based spatial statistics and tract-specific analysis.
Kamagata K; Motoi Y; Tomiyama H; Abe O; Ito K; Shimoji K; Suzuki M; Hori M; Nakanishi A; Sano T; Kuwatsuru R; Sasai K; Aoki S; Hattori N
Eur Radiol; 2013 Jul; 23(7):1946-55. PubMed ID: 23404139
[TBL] [Abstract][Full Text] [Related]
18. Neuroimaging and cognition in Parkinson's disease dementia.
Silbert LC; Kaye J
Brain Pathol; 2010 May; 20(3):646-53. PubMed ID: 20522090
[TBL] [Abstract][Full Text] [Related]
19. Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease.
Xu Y; Yang J; Hu X; Shang H
J Neurol; 2016 Jun; 263(6):1178-87. PubMed ID: 27113603
[TBL] [Abstract][Full Text] [Related]
20. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment.
Kandiah N; Mak E; Ng A; Huang S; Au WL; Sitoh YY; Tan LC
Parkinsonism Relat Disord; 2013 Jul; 19(7):680-3. PubMed ID: 23623194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
